Pharmafile Logo

Webinar: Observational Research

March 27, 2015 |  

Presenting a window on the world of your customer

Healthcare customers are changing. Marketers now need to understand the needs of many stakeholders, from patients and carers, to physicians, nurses and payers, amongst others, as well as the many channels of communication they are exposed to and utilise in both their work and home lives.

At Research Partnership we have been exploring the benefits of using Observational Research approaches, where the interviewer is less visible to the respondent, as a means of digging deeper and getting a more real, less ‘contaminated’ insight into the world of your customers.

In this webinar we will discuss some of the techniques we have been using, from traditional methods drawing on the principles of ethnography, to newer forms of observation using -mobile and digital technologies which allow us to be a distant observer of behaviour.

View this webinar to learn:

– Why observational research? Benefits and applications
– Approaches and techniques using a number of case studies   
– Using mobile research to understand prescribing decisions   
– Getting a truer picture of compliance behaviour   
– Assessing device usability using hand-held video cameras   
– Using ethnographics and accompanied visits to understand emerging markets   
– Simulated Consultations as a means of understanding patient/physicians interaction
– How to effectively apply observational techniques to achieve your objectives

To view this webinar please visit http://bit.ly/1BPDkBy 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Infographic: Are data blind spots putting your launch at risk?

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…

Key takeaways from ASCO® 2026

Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…

Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

From activity to impact: 5 takeaways from MAPS Americas 2026

Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…

Inizio launches Intelligent Congress: Turning medical event investment into measurable impact

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercializationâ„¢. Now we’re back in the…

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

How did multifaceted support from across Inizio help a biotech firm prepare for launch?

Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.

Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency

Explore Inizio Medical’s key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.